The Role of Osteopontin-OGDHL Axis in HFpEF

骨桥蛋白-OGDHL 轴在 HFpEF 中的作用

基本信息

  • 批准号:
    10524637
  • 负责人:
  • 金额:
    $ 9.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-02-01 至 2022-11-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT The goal of this minority supplement is to train and mentor an underrepresented Jamaican young lady during her transition from a medically-trained doctor to a physician scientist. Dr. Williams is an ambitious post-doctoral candidate who performed research via the Health Disparities & Cultural Identities research lab at Florida International University (FIU) assessing HPV risk. She was also a recipient of the South East Alliance for Graduate Education and the Professoriate (SEAGEP) award for undergraduate research in 2010. During this period, she assisted with the development of laboratory protocols for the Biomaterials laboratory at FIU. Dr. Williams was introduced to our team by another current Diversity Supplement awardee (Dr Julian Dunkley). Williams learnt about our NIH-funded HFpEF project and became very interested in training in basic and translation research. If granted, this postdoctoral supplement combined with the excellent environment, support, and extraordinary resources at the Interdisciplinary Stem Cell Institute and the University of Miami Miller School of Medicine will provide Dr. Williams with the tools and methodology necessary to become an independent physician scientist in the field of cardiovascular research where female Jamaican scientists are rare. This proposal is the logical extension of the parent grant entitled “Role of OPN-OGDHL Axis in HFpEF” (1R01HL140468) and is performed within the scope of the original project. As such, we will characterize the blood pressure and heart rhythm in the new HFpEF cardio-renal mouse model we recently characterized by implanting a telemetry device. We will assess the arrhythmia in the Alport mouse ± beta agonist/antagonists. The mice used will be from the three different genetic strains that we developed. This new approach barely modifies the proposed strategy and models, which keeps these additional experiments within the scope of the parent grant. The proposed experiments are anticipated to finish within the next 14 months.
抽象的 这项少数族裔补充计划的目标是培训和指导代表性不足的牙买加年轻人 女士从一名受过医学训练的医生转变为一名医学科学家。威廉姆斯博士是 一位雄心勃勃的博士后候选人,通过健康差异和 佛罗里达国际大学 (FIU) 文化身份研究实验室评估 HPV 风险。她 也是东南研究生教育联盟和教授的获得者 (SEAGEP) award for undergraduate research in 2010. During this period, she assisted with the 为佛罗里达国际大学生物材料实验室制定实验室协议。威廉姆斯博士是 由另一位现任多样性补充奖获得者(朱利安·邓克利博士)介绍给我们的团队。 Williams 了解了我们 NIH 资助的 HFpEF 项目,并对以下方面的培训非常感兴趣 基础研究和翻译研究。如果获得批准,该博士后补充品将与 跨学科干细胞的优良环境、支持和非凡资源 研究所和迈阿密大学米勒医学院将为威廉姆斯博士提供 成为该领域的独立医师科学家所需的工具和方法 牙买加女性科学家很少见的心血管研究领域。这个提议是合乎逻辑的 延长题为“OPN-OGDHL 轴在 HFpEF 中的作用”的母基金 (1R01HL140468) 并在原项目范围内进行。因此,我们将表征血液 我们最近在新的 HFpEF 心肾小鼠模型中测量了压力和心律 其特点是植入遥测装置。我们将评估 Alport 小鼠的心律失常 ± β 激动剂/拮抗剂。使用的小鼠将来自我们研究的三种不同的遗传品系 发达。这种新方法几乎没有修改所提出的策略和模型,这使得 这些额外的实验在父资助的范围内。提议的实验是 anticipated to finish within the next 14 months.

项目成果

期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Peptide-Functionalized Dendrimer Nanocarriers for Targeted Microdystrophin Gene Delivery.
  • DOI:
    10.3390/pharmaceutics13122159
  • 发表时间:
    2021-12-15
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Hersh J;Condor Capcha JM;Iansen Irion C;Lambert G;Noguera M;Singh M;Kaur A;Dikici E;Jiménez JJ;Shehadeh LA;Daunert S;Deo SK
  • 通讯作者:
    Deo SK
Methylene Blue Is a Nonspecific Protein-Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19.
  • DOI:
    10.3390/ph15050621
  • 发表时间:
    2022-05-18
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Chuang, Sung-Ting;Papp, Henrietta;Kuczmog, Anett;Eells, Rebecca;Capcha, Jose M. Condor;Shehadeh, Lina A.;Jakab, Ferenc;Buchwald, Peter
  • 通讯作者:
    Buchwald, Peter
Ascending aortic aneurysm and histopathology in Alport syndrome: a case report.
  • DOI:
    10.1186/s12882-023-03345-5
  • 发表时间:
    2023-10-12
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    Kamiar, Ali;Alitter, Qusai;Capcha, Jose M. C.;Saad, Ali;Webster, Keith A.;Shehadeh, Lina A.
  • 通讯作者:
    Shehadeh, Lina A.
Autoimmune Reaction Associated With Long COVID Syndrome and Cardiovascular Disease: A Genetic Case Report.
  • DOI:
    10.1016/j.jaccas.2022.09.014
  • 发表时间:
    2023-01-18
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Safronenka, Anita;Capcha, Jose M C;Webster, Keith A;Buglo, Elena;Tamariz, Leonardo;Goldberger, Jeffrey J;Shehadeh, Lina A
  • 通讯作者:
    Shehadeh, Lina A
Mouse Model of Heart Failure With Preserved Ejection Fraction Driven by Hyperlipidemia and Enhanced Cardiac Low-Density Lipoprotein Receptor Expression.
  • DOI:
    10.1161/jaha.122.027216
  • 发表时间:
    2022-09-06
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Williams, Monique;Capcha, Jose Manuel Condor;Irion, Camila Iansen;Seo, Grace;Lambert, Guerline;Kamiar, Ali;Yousefi, Keyan;Kanashiro-Takeuchi, Rosemeire;Takeuchi, Lauro;Saad, Ali G.;Mendez, Armando;Webster, Keith A.;Goldberger, Jeffrey J.;Hare, Joshua M.;Shehadeh, Lina A.
  • 通讯作者:
    Shehadeh, Lina A.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lina A Shehadeh其他文献

Lina A Shehadeh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lina A Shehadeh', 18)}}的其他基金

The Role of Osteopontin-OGDHL Axis in HFpEF
骨桥蛋白-OGDHL 轴在 HFpEF 中的作用
  • 批准号:
    9795565
  • 财政年份:
    2018
  • 资助金额:
    $ 9.49万
  • 项目类别:
Osteopontin Signals between Myocytes and Fibroblasts to Regulate Cardiac Remodeling
肌细胞和成纤维细胞之间的骨桥蛋白信号调节心脏重塑
  • 批准号:
    9336424
  • 财政年份:
    2016
  • 资助金额:
    $ 9.49万
  • 项目类别:
Mechanisms for miR-30e Regulated Atherogenic Pathways with Age
miR-30e随年龄调节动脉粥样硬化通路的机制
  • 批准号:
    8718967
  • 财政年份:
    2012
  • 资助金额:
    $ 9.49万
  • 项目类别:
Mechanisms for miR-30e Regulated Atherogenic Pathways with Age
miR-30e随年龄调节动脉粥样硬化通路的机制
  • 批准号:
    8549049
  • 财政年份:
    2012
  • 资助金额:
    $ 9.49万
  • 项目类别:
Mechanisms for miR-30e Regulated Atherogenic Pathways with Age
miR-30e随年龄调节动脉粥样硬化通路的机制
  • 批准号:
    8300301
  • 财政年份:
    2012
  • 资助金额:
    $ 9.49万
  • 项目类别:
Transcription Factor Networks in Cardiac Hypertrophy
心脏肥大中的转录因子网络
  • 批准号:
    7056336
  • 财政年份:
    2006
  • 资助金额:
    $ 9.49万
  • 项目类别:
Transcription Factor Networks in Cardiac Hypertrophy
心脏肥大中的转录因子网络
  • 批准号:
    7394365
  • 财政年份:
    2006
  • 资助金额:
    $ 9.49万
  • 项目类别:
Transcription Factor Networks in Cardiac Hypertrophy
心脏肥大中的转录因子网络
  • 批准号:
    7233688
  • 财政年份:
    2006
  • 资助金额:
    $ 9.49万
  • 项目类别:

相似海外基金

DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
  • 批准号:
    495592
  • 财政年份:
    2023
  • 资助金额:
    $ 9.49万
  • 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
  • 批准号:
    23K14885
  • 财政年份:
    2023
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
  • 批准号:
    10668025
  • 财政年份:
    2023
  • 资助金额:
    $ 9.49万
  • 项目类别:
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
  • 批准号:
    23K09597
  • 财政年份:
    2023
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
  • 批准号:
    514892030
  • 财政年份:
    2023
  • 资助金额:
    $ 9.49万
  • 项目类别:
    WBP Fellowship
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
  • 批准号:
    10638497
  • 财政年份:
    2023
  • 资助金额:
    $ 9.49万
  • 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
  • 批准号:
    10722857
  • 财政年份:
    2023
  • 资助金额:
    $ 9.49万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 9.49万
  • 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
  • 批准号:
    10724935
  • 财政年份:
    2023
  • 资助金额:
    $ 9.49万
  • 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
  • 批准号:
    10727929
  • 财政年份:
    2023
  • 资助金额:
    $ 9.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了